Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | RARB | P10826 | 1/20 | 0.48 |
| ▸ | RARG | P13631 | 1/20 | 0.48 |
| ▸ | TPMT | P51580 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloromethane SCHEMBL11451992 | 0.98 | SRD5A2 (0.57) | TSHRTP53ALOX15SRD5A2CA1 | |
| Hydrochloric Acid SCHEMBL11249823 | 0.98 | TSHR (0.57) | TSHRTP53ALOX15SRD5A2CA1 | |
| Methane SCHEMBL11452166 | 0.98 | TSHR (0.57) | TSHRTP53ALOX15SRD5A2CA1 | |
| Benzoic Acid SCHEMBL28194477 | 0.86 | TSHR (0.64) | TSHRTP53ALOX15SRD5A2ALDH1A1 | |
| SCHEMBL3551983 | 0.85 | TSHR (0.60) | TSHRTP53ALOX15SRD5A2CA1 | |
| SCHEMBL3701394 | 0.82 | SRD5A2 (0.50) | TSHRSRD5A2ALDH1A1CES2CES1 | |
| Terephthalic Acid SCHEMBL1243625 | 0.81 | TSHR (0.80) | TSHRTP53ALOX15SRD5A2CA1 | |
| SCHEMBL104711 | 0.80 | ALDH1A1 (0.45) | TSHRTP53SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL931931 | 0.79 | TSHR (0.54) | TSHRTP53ALOX15SRD5A2CA1 | |
| SCHEMBL2980698 | 0.79 | ALDH1A1 (0.61) | TSHRSRD5A2ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102968-A | Preparation method of modified polyurethane waterproof coating | 泰州市高士建筑材料科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-121272436-A | Catalytic system and method for electrochemical reduction and oxygenation of 1, 4-bis (trichloromethyl) benzene to 4- (trichloromethyl) benzoic acid | 浙江工业大学 | 2026-01-06 | — | — | CN | disclosed |
| CN-121272436-A | Catalytic system and method for electrochemical reduction and oxygenation of 1, 4-bis (trichloromethyl) benzene to 4- (trichloromethyl) benzoic acid | 浙江工业大学 | 2026-01-06 | — | — | CN | disclosed |
| US-20230176481-A1 | FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-08 | — | — | US | disclosed |
| CN-116102968-A | Preparation method of modified polyurethane waterproof coating | 泰州市高士建筑材料科技有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116102968-A | Preparation method of modified polyurethane waterproof coating | 泰州市高士建筑材料科技有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-115398342-A | Film-forming composition | 日产化学株式会社 | 2022-11-25 | — | — | CN | disclosed |
| US-8669375-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8318964-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-5296496-A | Treating degenerative diseases | STERLING WINTHROP INC. (US) | 1994-03-22 | — | — | US | disclosed |
| US-5250696-A | Treatment of degenerative diseases | STERLING WINTHROP INC. (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0550111-A1 | 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them | STERLING WINTHROP INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| EP-0550112-A1 | 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them | STERLING WINTHROP INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| EP-0549073-A1 | Novel 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1993-06-30 | — | — | EP | disclosed |
| US-5187173-A | Degenerative diseases such as emphysema, rheumatoid arthritis, pancreatitis, cyctic fibrosis and skin disorders | STERLING WINTHROP INC. (US) | 1993-02-16 | — | — | US | disclosed |
| US-5128339-A | Emphysema, rheumatoid arthritis, pancreatitis | STERLING WINTHROP INC. (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0483928-A1 | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use | STERLING WINTHROP INC. (US) | 1992-05-06 | — | — | EP | disclosed |
| EP-0440995-A1 | Process for preparing 1-octene | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-08-14 | — | — | EP | disclosed |
| US-5030792-A | Process for preparing 1-octene | SHELL OIL COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | TSHR 2444/4885TP53 1748/4885ALOX15 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.